Hailey Murphy Engineering AssociateAIChEHailey is currently an Engineering Associate at the American Institute of Chemical Engineers and works primarily with the Society for Biological Engineering. She graduated from the University of Delaware in 2017 with a Bachelors in Biomedical Engineering. During her undergraduate career, she was an undergraduate researcher in a nanomedicine lab, and interned at LafargeHolcim as an environmental compliance intern (2014-2016). After graduation, she worked as an associate scientist in an immunobioanalysis laboratory at Quest Pharmaceutical Services (QPS) in their translational medicine department. ChEnected contributions CAR T-Cell Therapy Individualizes Cancer Treatment Dec 27, 2018 . by Hailey Murphy The market for chimeric antigen receptor (CAR) T-cell therapy is projected to be valued at almost $300 million by the end of 2018, and this number is expected to grow annually by 32% for the next decade.